Clinical Trials
8 trialsNCT05549232 2025-07-23
Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital
Hemanext
Completed
NCT05019144 2025-07-11
TOBI
Medical University of South Carolina
Phase NA Completed
NCT05148390 2024-02-21
GELFI
BSN Medical GmbH
Completed
NCT00540566 2022-10-20
Optical Biopsy of Human Skin in Conjunction With Laser Treatment
University of California, Irvine
Completed
NCT02145130 2021-09-08
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
University of Zurich
Phase 1 Completed
NCT00236041 2014-05-09
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT00236093 2014-05-09
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed
NCT01302223 2012-12-06
Keratinocyte Growth Factor and Cytokines in Burns.
Federal University of São Paulo
Completed